Metals... Not Missles... Is the New Arms Race
China and Russia control 70% of the world's critical minerals, giving them leverage over the West. One N. American discovery could help shift that balance by developing the metals essential for defense systems.
Shares Stats
| Shares Outstanding | 146,700,000 |
| Shares Float | 146,440,000 |
| Shares Short | 5,640,000 |
| Insider Holdings | 15% |
| Institution Holdings | 94.92% |
About Biogen Inc
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally. The company provides TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, and TYSABRI for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; SKYCLARYS to treat Friedreich's Ataxia; QALSODY for treating amyotrophic lateral sclerosis; FUMADERM to treat plaque psoriasis; BENEPALI, an etanercept biosimilar referencing ENBREL; IMRALDI, an adalimumab biosimilar referencing HUMIRA; FLIXABI, an infliximab biosimilar referencing REMICADE; BYOOVIZ, a ranibizumab biosimilar referencing LUCENTIS; and TOFIDENCE, a tocilizumab biosimilar referencing ACTEMRA. It offers RITUXAN to treat non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL), rheumatoid arthritis, two forms of ANCA-associated vasculitis, and pemphigus vulgaris; RITUXAN HYCELA for non-Hodgkin's lymphoma and CLL; GAZYVA to treat CLL and follicular lymphoma; OCREVUS for relapsing MS and primary progressive MS; LUNSUMIO to treat relapsed or refractory follicular lymphoma; glofitamab for non-Hodgkin's lymphoma; and other anti-CD20 therapies. In addition, the company is developing products for the treatment of MS, Alzheimer's disease and dementia, neuromuscular disorders, Parkinson's disease and movement disorders, neuropsychiatry, and biosimilars. Biogen Inc. has collaboration and license agreements with Merz Therapeutics; Alkermes Pharma Ireland Limited; Denali Therapeutics Inc.; Eisai Co., Ltd.; Genentech, Inc.; Neurimmune SubOne AG; Ionis Pharmaceuticals, Inc.; and Sage Therapeutics, Inc., as well as collaborations with Fujirebio to identify and develop biomarkers for tau pathology in the brain and Stoke Therapeutics, Inc. for the development and commercialization of zorevunersen, a disease modifying medicine for the treatment of Dravet syndrome. The company was founded in 1978 and is headquartered in Cambridge, Massachusetts.
General
| Name | Biogen Inc |
| Ticker | BIIB |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
| Currency | USD |
| Country | USA |
| Fiscal Year End | December |
| Full Time Employees | 7,605 |
Highlights
| Analyst Target | 178.23 |
| Market Cap | 24,635,700,000 |
| PE Ratio | 15.31 |
| PEG Ratio | 6.24 |
| EBITDA | 3,409,299,968 |
Financials
| Curr Year EPS Estimate | 15.06 |
| Next Quarter EPS Estimate | 3.38 |
| Profit Margin | 16.60% |
| Operating Margin | 25.17 |
| Return on Assets | 0.06 |
| Return on Equity | 0.09 |
| Revenue | 9.7B |
| Earnings Per Share | 10.97 |
| Revenue Per Share | 68.82 |
| Gross Profit | 7,706,800,128 |
| Quarterly Revenue Growth | 0.03 |
Valuation
| Trailing PE | 15.39 |
| Forward PE | 10.54 |
| Price/Sales (Trailing 12 Mt.) | 2.46 |
| Price/Book (Most Recent Quarter) | 1.33 |
Earnings
Trump urges Treasury Secretary Bessent to take Federal Reserve job
WASHINGTON (AP) — For the second time in two days, President Donald Trump said Wednesday that he would like to appoint Treasury Secretary Scott Bessent to chair the Federal Reserve.
Leaked Documents Unveil Meta's $16 Billion Revenue Projection From Scam Ads
Leaked internal documents have revealed that Meta projected a revenue of approximately $16 billion from scam advertisements and banned goods in 2024.
Gold Near $4,073. Copper Tight. This Drill Hit Came Just in Time. - Ad
Dual exposure to two surging metals, plus 17.91% CuEq over mineable width, and infrastructure on site - this is what juniors dream of. And the market is just starting to notice.
Cathie Wood Confirms $1 Million Bitcoin Price Target Despite Market Volatility
Cathie Wood, CEO of ARK Invest, remains confident in Bitcoin‘s (CRYPTO: BTC) future, even in the face of market volatility.
Trump Wants Washington Commanders' $3.7 Billion Stadium Named After Him: Report
President Donald Trump is seeking to have the Washington Commanders' new $3.7 billion stadium named after him.
Trump Signs Law to Launch Dollar 2.0 - Ad
Trump just signed law S.1582, unleashing the biggest money shift in 100+ years. For the first time since 1913, private firms - not the Fed - can mint a "Dollar 2.0." Treasury says it could drain $6.6T from banks and pay 10X current savings rates. Early investors in minting firms could see 40X returns by 2032.
MacKenzie Scott Has Donated More Than $19 Billion, Yet Her Wealth Grows Faster
MacKenzie Scott, the billionaire philanthropist and ex-wife of Amazon founder Jeff Bezos, has donated a staggering $19.25 billion since 2020.
Marjorie Taylor Greene Goes Bargain Shopping, Discloses Buying These Two Stocks At 52-Week Lows
Congresswoman Marjorie Taylor Greene disclosed some new stocks recently. Unlike past trades in 2024 and 2025, the latest disclosure is rather unique.
Congress to Feature Trump on $100 Bill? - Ad
A shocking new plan was just introduced in Washington; to celebrate Trump's new "golden age" by placing him on the $100 bill. In the months ahead, this former Presidential Advisor predicts the government will release a massive multi-trillion-dollar asset which it has held back for more than a century.
Dan Ives Says Tech Stocks Will 'Rip Higher' Through Year-End Amid Growing AI Valuation Concerns: 'Bull Market Has 2 More Years Of Runway'
Tech bull Dan Ives predicts 2 more years of AI-driven tech bull market, cites Meta and Microsoft as table pounder.
Weekend Round-Up: Musk's Trillion-Dollar Pay, Ford's F-150 Lightning Dilemma And More
From Elon Musk's trillion-dollar pay package to Ford's F-150 Lightning EV Pickup Dilemma, this is what last week in the auto world was like.
Bloomberg says AI is a $50 trillion revolution. - Ad
And at the center of it... isn't NVIDIA. It's a tiny supplier NVIDIA cannot live without. Insiders like Griffin and Druckenmiller are dumping NVIDIA shares... and quietly piling into this obscure stock. And with NVIDIA set to make a major announcement on December 19 at 5pm, time is running out.
Apple Beats Earnings, $1 Billion Google AI Deal, Budget Mac And More: This Week In Appleverse
Apple had a busy week with earnings beats, AI partnerships, new product plans, and reflections on Steve Jobs' legacy.
Freeport Slashes Its Outlook, And Still Wins Over Analysts
FCX lowers production guidance for Grasberg mine, but Scotiabank analyst sees favorable risk-reward setup with strong balance sheet.
Copper and Gold in Scale, Not Just Grade - Ad
This isn't a narrow system. It's a thick, mineralized zone delivering copper and gold together - in a province with infrastructure in place. New drill targets are already being tested.
Can Solana Do What Bitcoin Can't? Amplify's New ETF Aims For 36% Income
Amplify ETFs, the issuer known for thematic and income-driven fund products, has just launched the Amplify Solana 3% Monthly Option Income ETF (BATS:SOLM), a first-of-its-kind product combining the growth momentum in Solana (CRYPTO:
Consumer Tech News (Oct 27-31): Nvidia Surpasses $5T Market Cap, Trump-Xi Meeting Concludes, Big Tech Report Earnings & More
Apple, Amazon, Microsoft, and Alphabet beat Q3 estimates with revenue and earnings growth. Trump and Xi conclude high-stakes meeting with trade, soybean, and resource agreements, potentially impacting U.S.-China economic relations and global markets.
America's Defense Future Starts Underground - Ad
A N. American metals project just caught the attention of Rio Tinto - a mining giant. With four projects in key regions, this firm is aligned with Washington's push to rebuild the defense-metal supply chain.
Jim Cramer: Chipotle Is 'Too Expensive,' Buy This Plane Maker
On "Mad Money," Cramer discusses Henry Schein, Bloom Energy, Tyler Technologies, Boeing and Chipotle Mexican Grill.
Pete Hegseth Says War Department Preparing For 'Action' In Nigeria
U.S. Defense Secretary Hegseth agrees with Trump's order to prepare for action in Nigeria to stop the killing of Christians by Islamist militants.
The Market Just Crossed a Dangerous Line - Ad
The man who predicted the 2008 crash and 2020 says today's soaring markets are NOT a bubble - they're something far stranger and more dangerous. He says it's about to change everything you know about money.
TSLA, PLTR, IREN And More: 5 Stocks That Dominated Investor Buzz This Week
Retail investors talked up five hot stocks this week (Nov. 3–7) on X and Reddit's r/WallStreetBets: TSLA, PLTR, MSTR, AMD, IREN.
Obesity, diabetes treatments fuel Eli Lilly growth and spark bidding war
The market for obesity and diabetes treatments remains scorching hot, funneling billions in sales to Eli Lilly and fueling a bidding war over another drugmaker.
From Strong to Stunning: New Drill Hole Sets a New Bar - Ad
Earlier holes showed 2.4% and 2.7% CuEq. This new hit just delivered 6.93% over nearly 20 metres. That's a game-changer - and it comes with deep insider alignment and an active program.
Celsius, DoorDash and HubSpot Are Among Top 10 Large Cap Losers Last Week (Nov. 3-Nov. 7): Are the Others in Your Portfolio?
These ten large-cap stocks were the worst performers last week. Are they a part of your portfolio?
Serbia passes a special bill enabling Trump's son-in-law to build luxury complex despite opposition
BELGRADE, Serbia (AP) — Serbian lawmakers on Friday passed a special law clearing the way for a proposed real estate project that would be financed by an investment company linked to Donald Trump’s son-in-law despite and legal hurdles.
I Believe Something Massive Is About to Hit the Crypto Market - Ad
A new Trump-backed law, the Genius Act, could trigger the biggest crypto boom yet and unleash a $19T windfall. Some plays have already jumped 177% to 749%. The move is early. Positioned investors could see even larger gains, including ways to benefit without buying coins.
'No hire' job market leaves unemployed in limbo as threats to economy multiply
WASHINGTON (AP) — When Carly Kaprive left a job in Kansas City and moved to Chicago a year ago, she figured it would take three to six months to find a new position. After all, the 32-year old project manager had never been unemployed for longer than three months.
Some Social Security Recipients Won't Have To Wait Until 2026 For COLA Hike
Social Security and SSI recipients will receive a 2.8% cost-of-living adjustment in 2026, with SSI beneficiaries seeing the increase a day earlier due to a federal holiday.
Metals... Not Missles... Is the New Arms Race - Ad
China and Russia control 70% of the world's critical minerals, giving them leverage over the West. One N. American discovery could help shift that balance by developing the metals essential for defense systems.
Abu Dhabi hosts oil summit as OPEC+ halts production hikes planned for first quarter of 2026
ABU DHABI, United Arab Emirates (AP) — Abu Dhabi hosted a major oil summit Monday, hours after the OPEC+ cartel and its allies said it would halt further production increases planned in the first quarter of 2026 over concerns of too much supply in the market.
Pfizer clinches deal for obesity drug developer Metsea after a bidding war with Novo Nordisk
NEW YORK (AP) — U.S. pharmaceutical giant Pfizer signed a deal to purchase development-stage obesity drugmaker Metsera Inc., winning a bidding war against Novo Nordisk, the Danish drugmaker behind weight-loss treatments Ozempic and Wegovy.
Gold Near $4,073. Copper Tight. This Drill Hit Came Just in Time. - Ad
Dual exposure to two surging metals, plus 17.91% CuEq over mineable width, and infrastructure on site - this is what juniors dream of. And the market is just starting to notice.
Why Did MediciNova Stock (MNOV) Jump Over 87% In After-Hours Trading?
MediciNova shares soared over 87% in after-hours trading on Thursday following the publication of promising research.
Criminal case against Boeing over deadly 737 Max plane crashes is dismissed by a US judge
A federal judge in Texas has agreed to dismiss a criminal conspiracy charge against Boeing in connection with two that killed 346 people.
Trump Signs Law to Launch Dollar 2.0 - Ad
Trump just signed law S.1582, unleashing the biggest money shift in 100+ years. For the first time since 1913, private firms - not the Fed - can mint a "Dollar 2.0." Treasury says it could drain $6.6T from banks and pay 10X current savings rates. Early investors in minting firms could see 40X returns by 2032.
Trump Touts 'Really Good Deal' With China As US Stock Futures Rally — Dow Up 91 Points While Gold, US Dollar Remain Flat
U.S. stock futures are surging on Sunday evening, following greater clarity and easing trade tensions between the United States and China over the weekend, following the summit between President Donald Trump and Chinese President Xi Jinping in South Korea last week.
Pfizer Clinches $10 Billion Deal To Buy Obesity Drug Maker Metsera, Outbidding Novo Nordisk In Fierce Battle For Weight-Loss Market Dominance
Nvidia CEO Jensen Huang cautioned Elon Musk against underestimating the challenges of semiconductor manufacturing, saying building a chip fab like TSMC's is "extremely hard."
Congress to Feature Trump on $100 Bill? - Ad
A shocking new plan was just introduced in Washington; to celebrate Trump's new "golden age" by placing him on the $100 bill. In the months ahead, this former Presidential Advisor predicts the government will release a massive multi-trillion-dollar asset which it has held back for more than a century.
S&P Global Boosts Outlook As CEO Hails Exceptional Growth
S&P Global (NYSE: SPGI) shares surge after reporting strong Q3 results, beating expectations with adjusted earnings of $4.73 per share.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.